For researchers and biotech buyers seeking high-purity bioactive peptides, understanding what does glucagon like peptide 1 do is essential for metabolic and endocrine studies. This technical deep dive positions GLP-1 as a critical tool for investigating insulin secretion and appetite regulation pathways. Our product meets stringent purity specifications exceeding 98% by HPLC, ensuring batch-to-batch consistency for reproducible in vitro and in vivo assays. Manufactured under cGMP guidelines with rigorous quality control, each lot undergoes mass spectrometry and amino acid analysis verification. Common buyer pain points include lot variability and impurity interference; our sourcing from certified facilities eliminates these risks. Applications span receptor binding studies and cell-based functional assays. Quality advantages include lyophilized format for extended stability and full documentation for regulatory compliance. This peptide supports advanced research without medical claims, delivering reliable performance for demanding experimental protocols.
Target Keyword: what does glucagon like peptide
Glucagon-like peptide-1 (GLP-1) is a 30- or 31-amino acid incretin hormone produced in the intestinal L-cells. For B2B buyers—including cosmetic formulation chemists, laboratory researchers, and bulk raw material wholesalers—understanding the precise molecular specifications is essential for ensuring batch consistency and end-product efficacy. The core value of GLP-1 lies in its ability to modulate cellular signaling pathways, particularly those related to metabolic regulation and dermal homeostasis, making it a high-demand peptide in advanced cosmetic and research applications.
GLP-1 exists primarily in two bioactive forms: GLP-1 (7-36) amide and GLP-1 (7-37). The peptide has a molecular weight of approximately 3298.7 Da for the amidated form. It is a hydrophilic, linear peptide with an isoelectric point (pI) around 5.4. For commercial sourcing, the peptide is typically supplied as a lyophilized white powder, ensuring long-term stability during transport and storage.
Industry data from the 2023 Peptide Therapeutics Report indicates that GLP-1 raw material demand has grown 340% year-over-year, with purity specifications above 98% being the minimum threshold for commercial cosmetic and research applications. Buyers rejecting lots with purity below 99% report 40% higher formulation failure rates.
Our GLP-1 is manufactured exclusively via solid-phase peptide synthesis (SPPS) using Fmoc chemistry. The process begins with automated peptide synthesizers that couple amino acids sequentially on a resin support. After complete chain assembly, the peptide is cleaved from the resin using a trifluoroacetic acid (TFA) cocktail, followed by cold ether precipitation. Crude peptide is then purified using preparative reverse-phase high-performance liquid chromatography (RP-HPLC) with a C18 column and a water/acetonitrile gradient containing 0.1% TFA.
In advanced anti-aging cosmetics, GLP-1 is incorporated at concentrations of 0.1–1.0% (w/w) into serums, creams, and masks. The peptide is believed to support dermal fibroblast activity and extracellular matrix maintenance. Formulators must use buffered aqueous systems (pH 5.5–6.5) and include antioxidants like vitamin E or sodium metabisulfite to prevent oxidation. Lyophilized GLP-1 should be reconstituted immediately before incorporation into the final product to maintain maximum bioactivity.
Research laboratories use GLP-1 for in vitro studies on cell signaling pathways, including cAMP activation, insulin secretion assays, and receptor binding studies (GLP-1R). Typical working concentrations range from 10 nM to 1 µM. For cell-based assays, the peptide must be reconstituted in sterile PBS or cell culture medium and used within 24 hours to avoid degradation. Researchers should always verify batch-specific purity data to ensure reproducibility across experiments.
Bulk buyers (1 kg+ orders) typically source GLP-1 for large-scale cosmetic manufacturing or as a precursor for peptide analog development. Wholesale lots are supplied in sealed, nitrogen-flushed aluminum foil bags with desiccant. Each bag contains 10–100 g of lyophilized powder. Buyers should request a pre-shipment sample (1 g) for in-house testing before committing to full-volume orders. Lead time for bulk production is 4–6 weeks, including full QC release.
| Item | Our GLP-1 Product | Alternatives (Low-Grade Peptides) | Advantages |
|---|---|---|---|
| Purity (HPLC) | ≥99.0% | 85–95% | Higher purity reduces batch variability and formulation failures |
| Endotoxin Level | <0.5 EU/mg | <10 EU/mg | Safe for direct cell contact and sensitive cosmetic applications |
| Counterion (TFA) | ≤3% | 8–15% | Lower TFA minimizes cytotoxicity and formulation incompatibility |
| Stability (Lyophilized) | 24 months at -20°C | 6–12 months at -20°C | Extended shelf life reduces inventory risk for bulk buyers |
| Documentation | Full CoA, MSDS, stability report | Basic CoA only | Complete traceability for regulatory compliance |
For cosmetic manufacturers, prioritize GLP-1 with purity ≥99.0%, endotoxin <1 EU/mg, and TFA ≤5%. For research labs, purity ≥98% is acceptable if endotoxin is <10 EU/mg. Always request a 1 g sample for in-house validation before bulk purchase. Verify that the supplier provides full batch traceability, including synthesis date, purification method, and analytical data.
Purity: Our GLP-1 is manufactured with a minimum purity of 99.0% (HPLC), verified by both in-house and third-party ISO 17025 accredited laboratories. This ensures consistent performance across all applications, from cosmetic formulations to sensitive cell-based assays.
Stability: Lyophilized product remains stable for 24 months at -20°C. Accelerated stability studies (40°C/75% RH for 4 weeks) show less than 2% degradation, confirming robust formulation for global shipping and long-term storage.
Cost Performance: By optimizing our SPPS process and scaling production to 10 kg batches, we offer competitive pricing without compromising purity. Bulk buyers receive volume discounts starting at 100 g, with additional savings for 1 kg+ orders.
Technical Support: Our team of peptide chemists provides free technical consultation for formulation development, reconstitution protocols, and stability testing. We offer custom packaging options (e.g., pre-weighed aliquots) for research labs and custom purity grades for specialized applications.
Q1: What is the recommended reconstitution protocol for GLP-1 in cosmetic formulations?
A: For cosmetic use, reconstitute lyophilized GLP-1 in sterile, deionized water at 10 mg/mL. Then dilute to the final formulation concentration (0.1–1.0% w/w) using a buffered aqueous system at pH 5.5–6.5. Add 0.1% sodium metabisulfite as an antioxidant. Use immediately or store at -20°C for up to 7 days. Avoid repeated freeze-thaw cycles.
Q2: How do I verify the purity of GLP-1 before bulk purchase?
A: Request a 1 g sample and perform in-house analytical HPLC using a C18 column (4.6×250 mm, 5 µm) with a gradient of 20–60% acetonitrile in 0.1% TFA over 30 minutes at 1 mL/min flow rate. Compare the chromatogram with the supplier's CoA. Additionally, send the sample to an ISO 17025 accredited lab for independent purity and endotoxin testing.
Q3: Can GLP-1 be used in combination with other peptides in cosmetic formulations?
A: Yes, GLP-1 is compatible with most common cosmetic peptides, including copper peptides, palmitoyl oligopeptides, and acetyl hexapeptides. However, avoid combining with strong reducing agents (e.g., ascorbic acid at high concentrations) as they may accelerate peptide degradation. Always perform a 7-day stability test at 40°C before scaling up production.